Cost-Effectiveness of a HPV-Vaccination Catch-Up Program for Females Aged 26 Years or Younger in a Norwegian Setting [Internet].

Infection with human papillomavirus (HPV) is documented to be associated with several precancerous lesions (CIN, VIN and VaIN), cancer and genital warts. In this economic evaluation, we evaluated the cost-effectiveness of administering a catch-up vaccine to females aged 26 years or younger in addition to the current practice of vaccinating 12 year-old- girls compared to maintaining the current practice.

http://ift.tt/2rpenVo